Cell cycle regulating kinase cdk4 as a potential target for tumor cell treatment and tumor imaging

Journal of Oncology

Volumn , Issue , 2009, Pages

  Pietzsch, Jens ^a   Graf, Franziska ^a   Koehler, Lena ^a   Kniess, Torsten ^a   Wuest, Frank ^b   Mosch, Birgit ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 6 IODO 5 METHYL 2 (4 PIPERAZIN 1 YLPHENYLAMINO) 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; 8 CYCLOPENTYL 6 IODO 5 METHYL 2 [5 (PIPERAZIN 1 YL)PYRIDIN 2 YLAMINO] 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; CYCLIN D; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 4 INHIBITOR; IODINE 124; MESSENGER RNA; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DISTRIBUTION; ENZYME BINDING; HUMAN; HUMAN CELL; IMAGE INTENSIFIER; IN VIVO STUDY; TARGET CELL;

EID: 68349104387     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2009/106378     Document Type: Article

References (37)

1. Ortega S., Malumbres M., Barbacid M., Cyclin D-dependent kinases, INK4 inhibitors and cancer Biochimica et Biophysica Acta 2002 1602 1 73 87
2. Deshpande A., Sicinski P., Hinds P. W., Cyclins and cdks in development and cancer: a perspective Oncogene 2005 24 17 2909 2915
3. Lees J. A., Buchkovich K. J., Marshak D. R., Anderson C. W., Harlow E., The retinoblastoma protein is phosphorylated on multiple sites by human cdc2 The EMBO Journal 1991 10 13 4279 4290
4. Connell-Crowley L., Harper J. W., Goodrich D. W., Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation Molecular Biology of the Cell 1997 8 2 287 301
5. Macaluso M., Montanari M., Giordano A., Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes Oncogene 2006 25 38 5263 5267
6. Lundberg A. S., Weinberg R. A., Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes Molecular and Cellular Biology 1998 18 2 753 761
7. Cobrinik D., Pocket proteins and cell cycle control Oncogene 2005 24 17 2796 2809
8. Kalma Y., Marash L., Lamed Y., Ginsberg D., Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2 Oncogene 2001 20 11 1379 1387
9. Moldovan G. L., Pfander B., Jentsch S., PCNA, the maestro of the replication fork Cell 2007 129 4 665 679
10. Wei G., Lonardo F., Ueda T., CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons International Journal of Cancer 1999 80 2 199 204
11. Perry A., Anderl K., Borell T. J., Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas American Journal of Clinical Pathology 1999 112 6 801 809
12. An H. X., Beckmann M. W., Reifenberger G., Bender H. G., Niederacher D., Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation The American Journal of Pathology 1999 154 1 113 118
13. Thoms H. C., Dunlop M. G., Stark L. A., CDK4 inhibitors and apoptosis: a novel mechanism requiring nucleolar targeting of RelA Cell Cycle 2007 6 11 1293 1297
14. Soni R., OReilly T., Furet P., Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4 Journal of the National Cancer Institute 2001 93 6 436 446
15. Fry D. W., Harvey P. J., Keller P. R., Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts Molecular Cancer Therapeutics 2004 3 11 1427 1438
16. Baughn L. B., Di Liberto M., Wu K., A novel orally active small molecule potently induces G 1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6 Cancer Research 2006 66 15 7661 7667
17. VanderWel S. N., Harvey P. J., McNamara D. J., Pyrido[2,3- d ]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4 Journal of Medicinal Chemistry 2005 48 7 2371 2387
18. Toogood P. L., Harvey P. J., Repine J. T., Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6 Journal of Medicinal Chemistry 2005 48 7 2388 2406
19. Varagnolo L., Stokkel M. P. M., Mazzi U., Pauwels E. K. J., 18 F-labeled radiopharmaceuticals for PET in oncology, excluding FDG Nuclear Medicine and Biology 2000 27 2 103 112
20. Bergmann R., Pietzsch J., Small animal positron emission tomography in food sciences Amino Acids 2005 29 4 355 376 (Pubitemid 41813492)
21. Vallabhajosula S., F 18 -labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization Seminars in Nuclear Medicine 2007 37 6 400 419
22. Eisenhut M., Mier W., Vrtes A., Nagy S., Klencsr Z., Radioiodination chemistry and radioiodinated compounds Handbook of Nuclear Chemistry 2003 Amsterdam, The Netherlands Kluwer Academic Publishers 257 278
23. Barvian M., Boschelli D. H., Cossrow J., Pyrido[2,3- d ]pyrimidin-7-one inhibitors of cyclin-dependent kinases Journal of Medicinal Chemistry 2000 43 24 4606 4616
24. Horowitz J. M., Park S. H., Bogenmann E., Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells Proceedings of the National Academy of Sciences of the United States of America 1990 87 7 2775 2779
25. Lee E. Y., To H., Shew J. Y., Bookstein R., Scully P., Lee W. H., Inactivation of the retinoblastoma susceptibility gene in human breast cancers Science 1988 241 4862 218 221
26. Shapiro G. I., Cyclin-dependent kinase pathways as targets for cancer treatment Journal of Clinical Oncology 2006 24 11 1770 1783
27. Bartek J., Vojtesek B., Grand R. J. A., Gallimore P. H., Lane D. P., Cellular localization and T antigen binding of the retinoblastoma protein Oncogene 1992 7 1 101 108
28. Liggett W. H. Jr., Sewell D. A., Rocco J., Ahrendt S. A., Koch W., Sidransky D., p 16 and p 16 are potent growth suppressors of head and neck squamous carcinoma cells in vitro Cancer Research 1996 56 18 4119 4123
29. Browne S. J., MacFarlane M., Cohen G. M., Paraskeva C., The adenomatous polyposis coli protein and retinoblastoma protein are cleaved early in apoptosis and are potential substrates for caspases Cell Death and Differentiation 1998 5 3 206 213
30. Kitagawa M., Higashi H., Jung H. K., The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2 The EMBO Journal 1996 15 24 7060 7069
31. Sellers W. R., Kaelin W. G., RB [corrected] as a modulator of transcription Biochimica et Biophysica Acta 1996 1288 1 M1 M5
32. Saab R., Bills J. L., Miceli A. P., Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells Molecular Cancer Therapeutics 2006 5 5 1299 1308
33. Baldwin S. A., Mackey J. R., Cass C. E., Young J. D., Nucleoside transporters: molecular biology and implications for therapeutic development Molecular Medicine Today 1999 5 5 216 224
34. Zhang J., Visser F., King K. M., Baldwin S. A., Young J. D., Cass C. E., The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs Cancer and Metastasis Reviews 2007 26 1 85 110
35. Wijnholds J., Mol C. A. A., van Deemter L., Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs Proceedings of the National Academy of Sciences of the United States of America 2000 97 13 7476 7481
36. Shields A. F., Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology Molecular Imaging and Biology 2006 8 3 141 150
37. Vandenberghe S., Three-dimensional positron emission tomography imaging with 124I and 86Y Nuclear Medicine Communications 2006 27 3 237 245